Robert Goldman, Daniel McGavock, and Richard Razgaitis were recognized in the latest edition of IAM Strategy 300 – The World’s Leading IP Strategists 2017, an annual listing of individuals with world class skills in the development and roll-out of strategies that maximize the value of patents, copyright, trademark, and other IP rights. The consultants were nominated multiple times by different parties as outstanding IP strategists.
Biosimilars: Economic Issues for IP Litigation
In July 2021, the U.S. Food and Drug Administration granted a determination of interchangeability to a biosimilar drug for the first time. This approval has...